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Abstract
Recently, a novel factor with anorexigenic properties was identified and called nesfatin-1. This
protein (82 aac) is not only expressed in peripheral organs but it is also found in neurons located
in specific structures including the hypothalamus and the brainstem, two sites strongly involved in
food intake regulation. Here, we studied whether some of the neurons that become activated
following an injection of an anorectic dose of lipopolysaccharides (LPS) exhibit a nesfatin-1
phenotype. To this end, we used double immunohistochemistry to target the expression of the
immediate-early gene c-fos and of nesfatin-1 on coronal frozen sections of the rat brain. The
number of c-Fos+/nesfatin-1+ neurons was evaluated in the immunosensitive structures reported
to contain nesfatin-1 neurons; i.e. paraventricular hypothalamic nucleus (PVN), supraoptic nucleus
(SON), arcuate nucleus (ARC) and nucleus of the solitary tract (NTS). LPS strongly increased the
number of c-Fos+/nesfatin-1+ neurons in the PVN, SON and NTS, and to a lesser extent in the
ARC. Triple labeling showed that a portion of the nesfatin-1 neurons activated in response to LPS
within the NTS are catecholaminergic since they co-express tyrosine hydroxylase (TH). Our data
therefore indicate that a portion of nesfatin-1 neurons of both the hypothalamus and brainstem are
sensitive to peripheral inflammatory signals, and provide the first clues suggesting that centrally
released nesfatin-1 may contribute to the neural mechanisms leading to endotoxaemic anorexia.
Findings
During infection and inflammation, the immune, endo-
crine and nervous systems closely interact to coordinate a
range of physiological and behavioral changes known as
the acute phase reaction. The behavioral symptoms collec-
tively referred to as "sickness behavior" include fever, ano-
rexia, adipsia, lethargy and reduction in social interactions
[1,2]. Cytokines peripherally released act on specific cen-
tral nuclei involved in feeding and homeostatic regula-
tion, which leads to the central component of the acute
phase response. The complex neuronal circuitry involved
in the coordinated response to inflammation, which
includes notably the nucleus of the solitary tract (NTS),
area postrema (AP), ventrolateral medulla, parabrachial
nucleus, paraventricular hypothalamic nucleus (PVN),
supraoptic nucleus (SON), arcuate nucleus (ARC) and
Published: 24 September 2009
Journal of Neuroinflammation 2009, 6:27 doi:10.1186/1742-2094-6-27
Received: 28 July 2009
Accepted: 24 September 2009
This article is available from: http://www.jneuroinflammation.com/content/6/1/27
© 2009 Bonnet et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Neuroinflammation 2009, 6:27 http://www.jneuroinflammation.com/content/6/1/27
Page 2 of 8
(page number not for citation purposes)
central nucleus of the amygdala, has been identified
mainly by quantification of the immediate-early gene c-fos
[3,4]. The expression of the c-fos gene is widely considered
to be a high resolution marker of neuronal activity, since
a body of evidence demonstrates that Fos protein is
expressed in neurons whose activity is strongly stimulated
by synaptic input [5]. Used in combination with immu-
nohistochemical determination of neuronal phenotype,
this approach has led to the identification and location of
neurons activated by inflammation and involved in the
triggering of sickness behavior [6-8].
Recently, Oh-I and co-authors reported the identification
of a novel factor with anorexigenic properties, which they
called nesfatin-1 [9]. Nesfatin-1 is reported to reduce food
intake both after central (3rd ventricle) and peripheral
administration [9,10]. Apart from adipose tissue, from
which nesfatin-1 was first isolated, this protein is also
expressed by gastric mucosa [11] and pancreatic β-cells
[12]. This pattern of nesfatin-1 expression, as well as the
presence of nesfatin-1 within the plasma of rodents and
humans, strongly suggests that this compound may act as
a circulating regulatory factor. Interestingly, expression of
nesfatin-1 within the brain has been reported by various
groups [13-16]. Neurons expressing nesfatin-1 are found
located in various areas including the brainstem (NTS,
dorsal motor nucleus of the vagus: DMNX) and hypotha-
lamic nuclei (ARC, PVN, SON).
In the present study, we investigated, by mean of a c-Fos/
nesfatin-1 double immunohistochemical approach,
whether a portion of those neurons activated in response
to peripheral injection of an anorexic dose of lipopolysac-
charides (LPS) exhibit nesfatin-1 expression. The periph-
eral injection of LPS is a well characterized model of
inflammation, known to induce events occurring during
sepsis such as the synthesis and release of inflammatory
cytokines and the activation of immunosensitive struc-
tures in the brain [2].
Adult male Wistar rats weighing 250-300 g (Janvier,
France) were housed individually in a pathogen-free facil-
ity at controlled temperature on a 12:12-h light/dark cycle
(lights off at 18.00 h) with food (AO4, SAFE UAR, France)
and water available ad libitum. All procedures were in
accordance with the European Directive N886/609 and
the local committees for animal use and care. For habitu-
ation, animals were handled and injected intraperito-
neally (i.p.) with physiological saline every day for at least
seven days before experiment. On the day of the experi-
ment, animals (n = 6 for each condition) were fasted at
9.00 h and the food was withdrawn until the animal sac-
rifice in order to avoid activation of nesfatin-1 neurons
consecutive to feeding. Four hours after the beginning of
fasting, animals were injected with either saline or an LPS-
containing solution (0.25 mg/kg, from E. coli, serotype
0127:B8, Sigma). The injection volume for all animals
was 0.01 ml per gram of body weight. The rats were sacri-
ficed three hours after injection, which corresponds to the
peak of neuronal c-Fos immunoreactivity in hypothala-
mus and brainstem nuclei following peripheral adminis-
tration of endotoxin [17]. After being deeply
anaesthetized with ketamine (100 mg/kg i.p.; Merial,
France) and xylazine (16 mg/kg i.p.; Bayer, France), rats
were transcardially perfused with freshly depolymerized
4% PFA. The brains were removed immediately, post-
fixed one hour in 4% PFA at 4°C and then cryoprotected
for 24 to 48 hours in 30% sucrose at 4°C.
To identify activated nesfatin-1 neurons, double immuno-
histochemistry for c-Fos and nesfatin-1 was performed on
brain sections. After freezing the brains in isopentane (-
40°C), coronal sections (40 μm thick) were cut on a cryo-
stat (Leica CM3050, France) and collected serially in 12-
well plates containing PBS (0.1 M). Brains were cut at the
brainstem level (Interaural -5.3 mm to -3.8) and at the
forebrain level (Interaural +4.7 to +7.7 mm) according to
the rat brain atlas from Paxinos and Watson [18]. The free-
floating sections were incubated in a solution containing
0.3% H2O2 in PBS 0.1 M for quenching of endogenous
peroxidase activity. A 1 h incubation in PBS containing
3% normal goat serum (NGS) and 0.3% Triton X-100 was
performed to block non-specific binding sites. Sections
were then treated for 48 hours at 4°C in PBS containing
3% NGS, 0.3% Triton X-100 and anti-c-Fos rabbit antise-
rum synthesized against amino acids 4-17 of human pro-
tein (1:10000, Ab-5, Calbiochem). After three washes in
PBS, the sections were incubated overnight at 4°C with
the biotinylated goat anti-rabbit IgG (1:400, Vector Labs).
After further washes, sections were incubated with avidin-
biotin complex (1:200, ABC Vector Elite kit) for 2 h at
room temperature. Horseradish peroxydase activity was
then visualized using a nickel-enhanced diaminobenzi-
dine (DAB) as the chromogen to reveal a purplish-black
stain of c-Fos-immunoreactive nuclei. The reaction
medium contained nickelous ammonium sulphate
(0.6%), DAB (0.006%) and H2O2 (0.02%) in PBS. The
reaction was closely monitored and terminated when
optimum intensity was achieved (10 min) by washing the
sections in distilled water. Non-specific labeling was
assessed on alternate slides that were treated identically to
the above but in which the primary antibody was omitted.
Sections were then incubated overnight at 4°C with a pri-
mary antibody raised against nesfatin-1 (1:10000, H-003-
22-B, Phoenix Pharmaceuticals Inc.), washed in PBS, and
incubated for 2 h at room temperature with a secondary
antibody conjugated with Alexa 488 (1:400, Vector Labs).
An additional labeling of the tyrosine hydroxylase (TH)
enzyme was performed on brainstem sections. For this
purpose, sections were incubated overnight at 4°C withJournal of Neuroinflammation 2009, 6:27 http://www.jneuroinflammation.com/content/6/1/27
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anti-TH antibody (1:1000, MAB318, Chemicon), and rev-
elation was performed using an Alexa 594-conjugated sec-
ondary antibody (1/400, Vector Labs). Finally, all sections
were mounted on gelatin-coated slides, air dried, and cov-
erslipped with mounting medium for fluorescence micro-
scope preparation (DAKO).
For the analysis of neuronal activation, images of brain
sections were acquired using 10× and 20× lenses with a
DXM 1200 Camera (Nikon) coupled to ACT-1 software.
Fluorescent images acquired at 520 nm were merged with
phase contrast images to allow visualization of c-Fos+/
nesfatin-1+ neurons. For each brain structure studied, the
counts performed on four distinct sections from both
hemispheres were averaged to yield the number of c-Fos
nuclei and c-Fos+/nesfatin-1+ cells per section. Statistical
analysis of data was performed with Sigmastat (version
3.5; Systat software Inc) using Student's t-test. P values less
than 0.05 were considered significant.
In the hypothalamus (Figure 1A-C) and brainstem (Figure
2A) of control animals injected with physiological saline
solution, c-Fos-labeled perikarya were very scarce. In con-
trast, rats treated with LPS exhibited an increased number
of c-Fos-positive nuclei in the hypothalamus and brain-
stem (Figures 1D-F and 2B). This increase in c-Fos immu-
noreactivity was clearly detected in the PVN (261.9 ± 12.5
versus 1.3 ± 0.2 c-Fos + nuclei per section in LPS and
A-F: Representative photomicrographs of c-Fos immunoreactivity in coronal sections of the PVN, ARC and SON Figure 1
A-F: Representative photomicrographs of c-Fos immunoreactivity in coronal sections of the PVN, ARC and 
SON. Images derived from saline-injected (A-C) and LPS-treated (D-F) rats. G-L: Analysis of c-Fos and nesfatin-1 (green) 
double-labeling in coronal sections through the hypothalamus of LPS-treated rats. Dashed boxes in low magnification images 
(G-I) indicate the area where high magnification images (J-L) originate. Arrowheads: c-Fos+/Nesf+ neurons; arrows: c-Fos+ 
neurons negative for nesfatin-1. ARC arcuate nucleus; ox, optic chiasm; PVN, paraventricular nucleus of the hypothalamus; 
SON: supraoptic nucleus; 3V, third ventricle. Scale bars: 200 μm (A-I), 50 μm (J-L).Journal of Neuroinflammation 2009, 6:27 http://www.jneuroinflammation.com/content/6/1/27
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saline-treated animals respectively; Figures 1A, D and 3),
the SON (69.7 ± 0.9 versus 2.0 ± 0.1 c-Fos + nuclei per sec-
tion; Figures 1B, E and 3) and the ARC (22.9 ± 0.9 versus
0.5 ± 0.1 c-Fos + nuclei per section; Figures 1C, F and 3).
At the brainstem level, visualisation of c-Fos immunoreac-
tivity revealed that LPS injection induced an increase in
positive perikarya mainly within the AP and the NTS (39.7
± 1.5 versus 0.7 ± 0.2 c-Fos + nuclei per section, Figures
2A, B and 2E). Nesfatin-1-immunoreactive neurons
expressing c-Fos (c-Fos+/Nesf+) were then analyzed in
hypothalamic and brainstem nuclei by means of double
immunohistochemistry in both experimental groups i.e
saline- and LPS-treated rats. As expected, all structures
studied were virtually devoid of c-Fos+/Nesf+ neurons in
control condition (Figures 2E and 3). In LPS-injected ani-
mals the greatest incidence of c-Fos/Nesf colocalization
was found in SON (Figures 1H, K and 3), where 51.9 ±
2.4% of total c-Fos perikarya also express nesfatin-1.
Lesser, but still highly significant, incidences were
observed in the PVN and NTS where the percentage of
colocalization reached 33.8 ± 2.3% and 19.71 ± 3.8%,
respectively (Figure 1G, J; Figures 2 C-E and 3). Interest-
ingly, the ARC exhibited less than 5% c-Fos/Nesf colocal-
ization, a value (4.7 ± 0.4%) which was nonetheless
significantly different from control animals (Figures 1I, L
and 3). It should be noted here that despite the increased
A-B: c-Fos immunoreactivity within the DVC Figure 2
A-B: c-Fos immunoreactivity within the DVC. Representative coronal sections of the DVC of saline-injected (A) and 
LPS-treated (B) rats. C-D: c-Fos and nesfatin-1 (green) double-labeling in coronal sections through the DVC of LPS-treated 
rats. D: High magnification of c-Fos/nesfatin-1 positive neurons in the NTS. Dashed box in C indicates the area where high 
magnification image originates. Arrowheads: c-Fos+/Nesf+ neurons; arrow: c-Fos+ neuron negative for nesfatin-1. E: Quantifi-
cation of the number of c-Fos and c-Fos/nesfatin-1 immunoreactive cells at the NTS subpostremal level of rats injected with 
either saline or LPS solution. Starred values are significantly different from saline-injected animals, *** p < 0.001. AP, area pos-
trema; cc, central canal; DMNX, dorsal motor nucleus of the vagus; NTS, nucleus of the solitary tract; ts, tractus solitarius. 
Scale bars: 100 μm (A-C), 50 μm (D).Journal of Neuroinflammation 2009, 6:27 http://www.jneuroinflammation.com/content/6/1/27
Page 5 of 8
(page number not for citation purposes)
number of c-Fos nuclei in the AP of LPS-treated animals
(Figure 2B), the absence of nesfatin-1 labeling in this area
(Figure 2C) naturally prompted us to exclude this nucleus
from our quantification. Finally, tyrosine hydroxylase
(TH) immunohistochemistry revealed that within the
NTS level some of the nesfatin-1 positive neurons were
catecholaminergic in nature since they co-expressed TH
(Figure 4A-C). Moreover, triple labeling for c-Fos/Nesf/TH
indicated that about 60% of the Nesf+/TH+ neurons were
activated during the immune challenge (Figure 4).
The present work confirms an hypothesized association
between nesfatin-1 neurons and inflammation since we
report here that some nesfatin-1-expressing neurons are
activated during an inflammatory stimulus. These results
therefore suggest that nesfatin-1 may intervene in the
onset of physiological and behavioral changes occurring
during acute phase reactions. The protocol used here, i.p.
injection of LPS coupled to c-Fos staining, is classically
employed to identify immunosensitive structures [3,4]. In
the present study, animals received an i.p. injection of LPS
at a concentration (0.25 mg/kg) reported to induce the
symptoms of the acute phase reaction including fever
[19], withdrawal [20] and anorexia [21] as well as c-Fos
protein production in central nuclei [4,19]. Under our
experimental conditions, the c-Fos distribution pattern
observed throughout the brain of LPS-injected rats was
consistent with the findings of previous studies performed
to identify neurocircuitry involved in the coordinated
physiological, endocrine, and behavioral response to LPS
challenge [4,22].
The evidence of nesfatin-1-expressing neurons activation
in the brainstem and hypothalamus emphasize the poten-
tial role played by these neurons in the transfer of infor-
mation received from circulating immune factors. We
observed that LPS injection substantially increased the
number of co-labeled neurons in key nuclei activated dur-
ing inflammation and involved in the coordinated physi-
ological, endocrine and behavioral changes characteristic
of sickness behavior. Nesfatin-1 has been reported to exert
an anorexigenic activity when administered either cen-
trally or peripherally [9,10]. Moreover, central nesfatin-1-
expressing neurons located in the hypothalamus or brain-
stem are reported to be activated by refeeding or after
cholecystokinine injection, which strongly suggests that
these neurons partake in the complex central neurocir-
cuitry involved in the termination of food intake [23,24].
The evidence that neurons expressing nesfatin-1, located
within both the hypothalamus and brainstem, are acti-
vated during inflammation support the hypothesis that
these neurons are involved in the reduction of food intake
induced by inflammation. Our results imply that nesfatin-
1, initially identified as a modulator of feeding behavior
under physiological conditions, could also be involved in
the modulation of feeding behavior during endotoxaemia
anorexia. Such a duality of peptide-expressing neurons
was first evoked for pro-opiomelanocortin and cortico-
trophin-releasing factor, hypothalamic neurons which
both play an essential role in the control of energy home-
ostasis and are likely to be involved in inflammatory ano-
rexia [25]. Finally, we cannot rule out the possibility that
nesfatin-1 neurons activated by inflammatory signals con-
Quantification of the number of c-Fos and c-Fos/nesfatin-1 immunoreactive cells in the PVN, SON and ARC after an i.p. injec- tion of either saline or LPS solution Figure 3
Quantification of the number of c-Fos and c-Fos/nesfatin-1 immunoreactive cells in the PVN, SON and ARC 
after an i.p. injection of either saline or LPS solution. Starred values are significantly different from saline-injected rats, 
** p < 0.01; *** p < 0.001.Journal of Neuroinflammation 2009, 6:27 http://www.jneuroinflammation.com/content/6/1/27
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tribute to other features of the acute-phase response. It has
been proposed that the activation of neurons located in
the SON contribute to a counter-hormonal response to
inflammation via the release of neurohypophysial hor-
mones into the circulation [26]. Interestingly, we show
here that a significant fraction of LPS-activated neurons
within the SON express nesfatin-1. The functional signifi-
cance of such activation of nesfatin-1-expressing neurons
in response to inflammation in this structure should be
explored in future studies.
Double staining revealed that a large number of nesfatin-
1 immunoreactive neurons of the NTS are positive for TH,
indicating that a fraction of nesfatin-1 neurons belong to
the A2/C2 catecholaminergic group. In accordance with
the previous observation by Lacroix and Rivest [4], who
reported an activation of TH-immunoreactive neurons of
the NTS in response to immune challenge, triple labeling
performed in the present study revealed the presence of c-
Fos/nesfatin-1-positive neurons immunoreactive for TH.
The activation of neurons coexpressing TH and nesfatin-1
in response to LPS might contribute to cardiovascular
response to endotoxin, which consists mainly in a modi-
fication in blood pressure and heart rate [27], since cate-
cholaminergic neurons of the NTS are involved in the
regulation of cardiovascular parameters [28], and cen-
trally injected nesfatin-1 was recently shown to affect
mean arterial pressure in conscious rats [29]. The presence
of c-Fos/nesfatin-1/TH triple labeled neurons in the NTS
of LPS-treated rats leads also to the hypothesis that some
of the nesfatin-1 neurons activated by immune challenge
project to the hypothalamus. Prior research has demon-
strated, for instance, the existence of catecholaminergic
projections from NTS to PVN [30]. The coupling of neuro-
nal pathway tracing studies with triple immunohisto-
Representative photomicrographs of c-Fos (DAB precipitate)/nesfatin-1 (green)/TH (red) triple labeling performed on brain- stem coronal sections of rats treated with LPS Figure 4
Representative photomicrographs of c-Fos (DAB precipitate)/nesfatin-1 (green)/TH (red) triple labeling per-
formed on brainstem coronal sections of rats treated with LPS. Note the presence of c-Fos positive neurons co-
expressing nesfatin-1 and TH (arrowheads), c-Fos+/Nesf+ neuron negative for TH (arrow) and c-Fos+/Nesf-/TH-neuron 
(asterisk). Dashed box in image (A) indicates the area where high magnification images (D-E) originate. AP, area postrema; cc, 
central canal; DMNX, dorsal motor nucleus of the vagus; NTS, nucleus of the solitary tract; ts, tractus solitarius. Scale bars: 
150 μm (A-C); 40 μM (D-F).Journal of Neuroinflammation 2009, 6:27 http://www.jneuroinflammation.com/content/6/1/27
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chemical labelling should be performed in the future to
answer this query.
In conclusion, we show for the first time that neurons of
the central nesfatinergic system are sensitive to peripheral
inflammatory stimulus and thus belong to the specific
immunosensitive neurocircuitry activated during infec-
tion or inflammation. Given the anorexigenic properties
described for nesfatin-1 and the presence of nesfatin-1-
activated neurons in key nuclei of the hypothalamus and
brainstem known to contribute to food intake regulation
[31], one may suggest that nesfatin-1 could account for
the reduction in food intake observed during endotoxae-
mic anorexia. This knowledge will help better understand
the neural mechanisms underlying sickness behavior.
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